This was confirmed by knocking down UCP2 expression in human hepatic cancer HEPG2 cells, leading to an increase in the mitochondrial membrane potential and ATP/ADP ratio, and a corresponding decrease in mitochondrial temperature [75]. This evidence concerns the gene UCP2 and liver cancer.